| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.05e-08 | 27 | 119 | 6 | GO:0008106 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.32e-08 | 14 | 119 | 5 | GO:0001758 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 1.98e-08 | 15 | 119 | 5 | GO:0052650 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.15e-08 | 32 | 119 | 6 | GO:0004033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 3.95e-07 | 48 | 119 | 6 | GO:0016620 | |
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 8.22e-07 | 4 | 119 | 3 | GO:0047655 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.00e-06 | 56 | 119 | 6 | GO:0016903 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.15e-06 | 14 | 119 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | ABC-type polyamine transporter activity | 3.52e-05 | 2 | 119 | 2 | GO:0015417 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 4.37e-05 | 12 | 119 | 3 | GO:0140852 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.13e-04 | 127 | 119 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.79e-04 | 138 | 119 | 6 | GO:0016614 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 2.10e-04 | 4 | 119 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | serotonin-gated monoatomic cation channel activity | 3.48e-04 | 5 | 119 | 2 | GO:0022850 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 3.48e-04 | 5 | 119 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 5.20e-04 | 6 | 119 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | serotonin receptor activity | 5.20e-04 | 6 | 119 | 2 | GO:0099589 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 7.25e-04 | 7 | 119 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 7.25e-04 | 7 | 119 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | ephrin receptor binding | 9.02e-04 | 32 | 119 | 3 | GO:0046875 | |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 9.63e-04 | 8 | 119 | 2 | GO:0000253 | |
| GeneOntologyMolecularFunction | carbonyl reductase (NADPH) activity | 1.23e-03 | 9 | 119 | 2 | GO:0004090 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.23e-03 | 9 | 119 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 1.87e-03 | 11 | 119 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 1.87e-03 | 11 | 119 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.87e-03 | 11 | 119 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 2.11e-03 | 473 | 119 | 9 | GO:0004842 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.14e-03 | 43 | 119 | 3 | GO:0005231 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.95e-06 | 147 | 117 | 8 | GO:0099565 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 5.43e-06 | 286 | 117 | 10 | GO:0042445 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.16e-05 | 89 | 117 | 6 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.59e-05 | 94 | 117 | 6 | GO:0016101 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 2.07e-05 | 10 | 117 | 3 | GO:0097151 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.98e-05 | 105 | 117 | 6 | GO:0006721 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle priming | 3.19e-05 | 2 | 117 | 2 | GO:0010808 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | RELN BCHE IDE RAB44 SIRT3 GH2 DHRS4 AKR1B10 AKR1B15 SCPEP1 ABCC2 AKR1B1 BAIAP3 ECE2 | 3.35e-05 | 684 | 117 | 14 | GO:0010817 |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 3.77e-05 | 12 | 117 | 3 | GO:0098828 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 4.00e-05 | 34 | 117 | 4 | GO:0032252 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 7.59e-05 | 180 | 117 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 7.70e-05 | 15 | 117 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 9.86e-05 | 130 | 117 | 6 | GO:0060079 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | UNC13B SYNE1 ATP13A2 TF ANKRD13A SLC11A1 PIK3CB EEF2K CACNA1G RIMS1 BAIAP3 RAB26 HCK | 1.06e-04 | 667 | 117 | 13 | GO:0060627 |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 1.73e-04 | 144 | 117 | 6 | GO:0006720 | |
| GeneOntologyBiologicalProcess | exocytosis | UNC13B ATP13A2 RAB44 PIK3CG EXOC6B CACNA1G RIMS1 BAIAP3 RAB26 HCK | 1.84e-04 | 434 | 117 | 10 | GO:0006887 |
| GeneOntologyBiologicalProcess | retinol metabolic process | 2.32e-04 | 53 | 117 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 2.58e-04 | 291 | 117 | 8 | GO:0045055 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system process | 3.08e-04 | 57 | 117 | 4 | GO:0031646 | |
| GeneOntologyBiologicalProcess | regulation of dense core granule exocytosis | 3.15e-04 | 5 | 117 | 2 | GO:1905413 | |
| GeneOntologyCellularComponent | late endosome | GRIN2B ATP13A2 TF ANKRD13A SLC11A1 CLCN3 CLCN4 ATP13A3 BAIAP3 | 1.95e-04 | 348 | 121 | 9 | GO:0005770 |
| GeneOntologyCellularComponent | HULC complex | 1.98e-04 | 4 | 121 | 2 | GO:0033503 | |
| GeneOntologyCellularComponent | serotonin-activated cation-selective channel complex | 3.29e-04 | 5 | 121 | 2 | GO:1904602 | |
| GeneOntologyCellularComponent | serotonin receptor complex | 3.29e-04 | 5 | 121 | 2 | GO:0098665 | |
| GeneOntologyCellularComponent | CKM complex | 3.29e-04 | 5 | 121 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | late endosome membrane | 6.18e-04 | 179 | 121 | 6 | GO:0031902 | |
| Domain | ALDOKETO_REDUCTASE_1 | 2.78e-07 | 10 | 115 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 2.78e-07 | 10 | 115 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 2.78e-07 | 10 | 115 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 2.78e-07 | 10 | 115 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 2.78e-07 | 10 | 115 | 4 | IPR020471 | |
| Domain | - | 2.34e-06 | 16 | 115 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 3.05e-06 | 17 | 115 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 3.05e-06 | 17 | 115 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 3.05e-06 | 17 | 115 | 4 | IPR001395 | |
| Domain | ANKS1 | 3.76e-05 | 2 | 115 | 2 | IPR033635 | |
| Domain | KASH | 2.24e-04 | 4 | 115 | 2 | IPR012315 | |
| Domain | P5-ATPase | 2.24e-04 | 4 | 115 | 2 | PF12409 | |
| Domain | KASH | 2.24e-04 | 4 | 115 | 2 | PS51049 | |
| Domain | KASH | 2.24e-04 | 4 | 115 | 2 | SM01249 | |
| Domain | KASH | 2.24e-04 | 4 | 115 | 2 | PF10541 | |
| Domain | PI3K_ABD | 2.24e-04 | 4 | 115 | 2 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 2.24e-04 | 4 | 115 | 2 | IPR003113 | |
| Domain | - | 3.10e-04 | 148 | 115 | 6 | 2.60.40.150 | |
| Domain | Spectrin | 3.68e-04 | 23 | 115 | 3 | PF00435 | |
| Domain | ACTININ_2 | 3.68e-04 | 23 | 115 | 3 | PS00020 | |
| Domain | ACTININ_1 | 3.68e-04 | 23 | 115 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.68e-04 | 23 | 115 | 3 | IPR001589 | |
| Domain | Munc13_dom-2 | 3.71e-04 | 5 | 115 | 2 | IPR014772 | |
| Domain | MHD2 | 3.71e-04 | 5 | 115 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 3.71e-04 | 5 | 115 | 2 | IPR019558 | |
| Domain | P-type_TPase_V | 3.71e-04 | 5 | 115 | 2 | IPR006544 | |
| Domain | Membr_traf_MHD | 3.71e-04 | 5 | 115 | 2 | PF10540 | |
| Domain | C2_dom | 5.35e-04 | 164 | 115 | 6 | IPR000008 | |
| Domain | Alpha_kinase | 5.55e-04 | 6 | 115 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 5.55e-04 | 6 | 115 | 2 | IPR004166 | |
| Domain | ALPHA_KINASE | 5.55e-04 | 6 | 115 | 2 | PS51158 | |
| Domain | Alpha_kinase | 5.55e-04 | 6 | 115 | 2 | SM00811 | |
| Domain | Spectrin_repeat | 7.39e-04 | 29 | 115 | 3 | IPR002017 | |
| Domain | Munc13_1 | 7.74e-04 | 7 | 115 | 2 | IPR014770 | |
| Domain | PI3K_Ras-bd_dom | 7.74e-04 | 7 | 115 | 2 | IPR000341 | |
| Domain | MHD1 | 7.74e-04 | 7 | 115 | 2 | PS51258 | |
| Domain | PI3K_rbd | 7.74e-04 | 7 | 115 | 2 | SM00144 | |
| Domain | DUF1041 | 7.74e-04 | 7 | 115 | 2 | PF06292 | |
| Domain | CAPS_dom | 7.74e-04 | 7 | 115 | 2 | IPR010439 | |
| Domain | PI3K_rbd | 7.74e-04 | 7 | 115 | 2 | PF00794 | |
| Domain | PI3K_RBD | 7.74e-04 | 7 | 115 | 2 | PS51546 | |
| Domain | SPEC | 9.90e-04 | 32 | 115 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.90e-04 | 32 | 115 | 3 | IPR018159 | |
| Domain | PI3K_C2 | 1.03e-03 | 8 | 115 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 1.03e-03 | 8 | 115 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 1.03e-03 | 8 | 115 | 2 | PF00792 | |
| Domain | PI3K_C2 | 1.03e-03 | 8 | 115 | 2 | PS51547 | |
| Domain | ARM-type_fold | 1.19e-03 | 339 | 115 | 8 | IPR016024 | |
| Domain | Cl-channel_core | 1.32e-03 | 9 | 115 | 2 | IPR014743 | |
| Domain | PI3Ka | 1.32e-03 | 9 | 115 | 2 | PF00613 | |
| Domain | - | 1.32e-03 | 9 | 115 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.32e-03 | 9 | 115 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.32e-03 | 9 | 115 | 2 | IPR001807 | |
| Domain | PI3Ka | 1.32e-03 | 9 | 115 | 2 | SM00145 | |
| Domain | - | 1.32e-03 | 9 | 115 | 2 | 1.25.40.70 | |
| Domain | PI_Kinase | 1.64e-03 | 10 | 115 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 1.64e-03 | 10 | 115 | 2 | IPR001263 | |
| Domain | PIK_HELICAL | 1.64e-03 | 10 | 115 | 2 | PS51545 | |
| Domain | WWE | 2.38e-03 | 12 | 115 | 2 | PF02825 | |
| Domain | WWE-dom | 2.38e-03 | 12 | 115 | 2 | IPR004170 | |
| Domain | WWE | 2.38e-03 | 12 | 115 | 2 | PS50918 | |
| Domain | PI3/4_kinase_CS | 3.74e-03 | 15 | 115 | 2 | IPR018936 | |
| Domain | - | 4.18e-03 | 106 | 115 | 4 | 1.10.150.50 | |
| Domain | CBS | 4.26e-03 | 16 | 115 | 2 | SM00116 | |
| Domain | - | 4.26e-03 | 16 | 115 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.26e-03 | 16 | 115 | 2 | SM00146 | |
| Domain | Methyltransf_11 | 4.26e-03 | 16 | 115 | 2 | IPR013216 | |
| Domain | Methyltransf_11 | 4.26e-03 | 16 | 115 | 2 | PF08241 | |
| Domain | PI3_PI4_kinase | 5.39e-03 | 18 | 115 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.39e-03 | 18 | 115 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.39e-03 | 18 | 115 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.39e-03 | 18 | 115 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.39e-03 | 18 | 115 | 2 | PS50290 | |
| Domain | SAM/pointed | 5.93e-03 | 117 | 115 | 4 | IPR013761 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.00e-03 | 19 | 115 | 2 | IPR004014 | |
| Pubmed | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. | 4.11e-08 | 3 | 121 | 3 | 17381426 | |
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 10092857 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 19339555 | ||
| Pubmed | 1.30e-06 | 225 | 121 | 8 | 12168954 | ||
| Pubmed | RNGTT MARS1 SYNE1 EPB41L5 GON4L ERBIN MPRIP CCNC KMT2C EEF1B2 DST ITSN2 NCAPD2 BYSL POLR1B FAR1 MED12 MAN1B1 | 4.40e-06 | 1497 | 121 | 18 | 31527615 | |
| Pubmed | 5.04e-06 | 360 | 121 | 9 | 33111431 | ||
| Pubmed | IL12RB1 MARS1 SYNE1 ANKS1B GRIN2B ERBIN TF MPRIP EEF1B2 DST RNPEP AKR1B10 ITSN2 MRPS9 RIMS1 AKR1B1 HCK | 9.76e-06 | 1431 | 121 | 17 | 37142655 | |
| Pubmed | IL12RB1 ACADVL SYNE1 ANKS1B DCC ERBIN EEF1B2 DST CLCN3 CLCN4 SYNE2 ITSN2 NCAPD2 MRPS9 RIMS1 ABCC2 CFAP46 | 1.08e-05 | 1442 | 121 | 17 | 35575683 | |
| Pubmed | Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. | 1.15e-05 | 13 | 121 | 3 | 17192785 | |
| Pubmed | Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. | 1.20e-05 | 2 | 121 | 2 | 34954342 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23928294 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15745835 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22354749 | ||
| Pubmed | Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. | 1.20e-05 | 2 | 121 | 2 | 25120755 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21087085 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8526877 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11792814 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 36518763 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 1.20e-05 | 2 | 121 | 2 | 24931616 | |
| Pubmed | Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments. | 1.20e-05 | 2 | 121 | 2 | 28972156 | |
| Pubmed | Alternative transcription initiation and splicing variants of the DHRS4 gene cluster. | 1.20e-05 | 2 | 121 | 2 | 18754758 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 37422774 | ||
| Pubmed | Munc13-1 is required for presynaptic long-term potentiation. | 1.20e-05 | 2 | 121 | 2 | 21849565 | |
| Pubmed | Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. | 1.20e-05 | 2 | 121 | 2 | 33644071 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32753644 | ||
| Pubmed | RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone. | 1.20e-05 | 2 | 121 | 2 | 11797009 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30692271 | ||
| Pubmed | Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks. | 1.20e-05 | 2 | 121 | 2 | 33945128 | |
| Pubmed | Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry. | 1.20e-05 | 2 | 121 | 2 | 28003428 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23146748 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11725818 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11903051 | ||
| Pubmed | Functional expression of novel human and murine AKR1B genes. | 1.20e-05 | 2 | 121 | 2 | 21276782 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18056116 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31911858 | ||
| Pubmed | Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism. | 1.20e-05 | 2 | 121 | 2 | 29617059 | |
| Pubmed | Uncoupling endosomal CLC chloride/proton exchange causes severe neurodegeneration. | 1.20e-05 | 2 | 121 | 2 | 32118314 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22768332 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12502714 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15473316 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24100137 | ||
| Pubmed | Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. | 1.20e-05 | 2 | 121 | 2 | 28929377 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17230527 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 1.20e-05 | 2 | 121 | 2 | 17267447 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 7578036 | ||
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 1.20e-05 | 2 | 121 | 2 | 24718612 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8541228 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24586179 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32628753 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18544649 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12732097 | ||
| Pubmed | RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease. | 1.20e-05 | 2 | 121 | 2 | 34088983 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17761684 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31578382 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15157181 | ||
| Pubmed | Identification and characterization of a novel human aldose reductase-like gene. | 1.20e-05 | 2 | 121 | 2 | 9565553 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25538260 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25406378 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20738173 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21329684 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34290256 | ||
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 19874786 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | ACADVL MARS1 PPA1 HUWE1 TF MPRIP ANKRD13A EEF1B2 ARL1 NCAPD2 FAR1 | 1.71e-05 | 647 | 121 | 11 | 26618866 |
| Pubmed | 1.80e-05 | 322 | 121 | 8 | 26514267 | ||
| Pubmed | 1.81e-05 | 15 | 121 | 3 | 20702582 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ACACA MARS1 EPB41L5 PPA1 HUWE1 ERBIN MPRIP EEF1B2 DST ERAL1 RNF20 NCAPD2 BYSL POLR1B FAR1 MED12 | 1.93e-05 | 1353 | 121 | 16 | 29467282 |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 2.12e-05 | 95 | 121 | 5 | 29643511 | |
| Pubmed | 2.23e-05 | 16 | 121 | 3 | 20880607 | ||
| Pubmed | 3.23e-05 | 18 | 121 | 3 | 29507117 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 27323117 | ||
| Pubmed | RNF20-RNF40: A ubiquitin-driven link between gene expression and the DNA damage response. | 3.59e-05 | 3 | 121 | 2 | 21827756 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10333503 | ||
| Pubmed | PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. | 3.59e-05 | 3 | 121 | 2 | 18187452 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 21862451 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20525226 | ||
| Pubmed | PI3Kβ plays a critical role in neutrophil activation by immune complexes. | 3.59e-05 | 3 | 121 | 2 | 21487106 | |
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 3.59e-05 | 3 | 121 | 2 | 16079285 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12680773 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 7510692 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19515725 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 21192076 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12163476 | ||
| Pubmed | Functional interaction of the active zone proteins Munc13-1 and RIM1 in synaptic vesicle priming. | 3.59e-05 | 3 | 121 | 2 | 11343654 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 27531651 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17875921 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12801637 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 38123547 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22021426 | ||
| Pubmed | Uncommon somatic mutations in metastatic NUT midline carcinoma. | 3.59e-05 | 3 | 121 | 2 | 28967088 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16704978 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17908814 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10878022 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 27798111 | ||
| Pubmed | Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth. | 3.59e-05 | 3 | 121 | 2 | 22155569 | |
| Pubmed | Regulation and roles of PI3Kβ, a major actor in platelet signaling and functions. | 3.59e-05 | 3 | 121 | 2 | 21035500 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15330860 | ||
| Pubmed | Role and regulation of phosphatidylinositol 3-kinase β in platelet integrin α2β1 signaling. | 3.59e-05 | 3 | 121 | 2 | 22106345 | |
| Pubmed | Ubiquitylation of cyclin C by HACE1 regulates cisplatin-associated sensitivity in gastric cancer. | 3.59e-05 | 3 | 121 | 2 | 35343092 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12408964 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12119107 | ||
| Cytoband | 3q27.1 | 4.99e-05 | 27 | 121 | 3 | 3q27.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q27 | 3.81e-04 | 128 | 121 | 4 | chr3q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q33 | 4.96e-04 | 58 | 121 | 3 | chr7q33 | |
| GeneFamily | Aldo-keto reductases | 7.86e-07 | 15 | 91 | 4 | 399 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.49e-04 | 4 | 91 | 2 | 1252 | |
| GeneFamily | 5-hydroxytryptamine receptors, ionotropic | 2.48e-04 | 5 | 91 | 2 | 172 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 2.48e-04 | 5 | 91 | 2 | 1213 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 6.88e-04 | 8 | 91 | 2 | 831 | |
| GeneFamily | Chloride voltage-gated channels | 1.10e-03 | 10 | 91 | 2 | 302 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN | 3.85e-06 | 197 | 121 | 8 | M8561 | |
| Coexpression | GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 1.68e-05 | 174 | 121 | 7 | M9007 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_500 | 1.61e-05 | 56 | 120 | 5 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.82e-07 | 178 | 121 | 7 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.54e-07 | 185 | 121 | 7 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.07e-06 | 195 | 121 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.07e-06 | 195 | 121 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.68e-06 | 168 | 121 | 6 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.91e-06 | 169 | 121 | 6 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.15e-06 | 170 | 121 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 7.90e-06 | 173 | 121 | 6 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.71e-06 | 176 | 121 | 6 | 8eb91dcf55d4e3e28a72d447181bf6d2ad891fc6 | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-06 | 178 | 121 | 6 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.16e-05 | 185 | 121 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 189 | 121 | 6 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 191 | 121 | 6 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.43e-05 | 192 | 121 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.56e-05 | 195 | 121 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 198 | 121 | 6 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 198 | 121 | 6 | 99d6a64f3410dae3019161feef20a8f06081a24b | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 121 | 6 | 6dc446a5d183b01bdf227e45bd88d0b3d8b1c56a | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 200 | 121 | 6 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.80e-05 | 200 | 121 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, condition lineage and cell class | 1.80e-05 | 200 | 121 | 6 | 186852d54eced4c036876cc891773605068b56b5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | (51)_cDC1|World / shred on Cell_type and subtype | 2.01e-05 | 204 | 121 | 6 | a8cf4180c406674b7541917d1fc6127686ba5f8a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-05 | 145 | 121 | 5 | ab0e254a8d01021619853a6c175f620ccef217d8 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-05 | 145 | 121 | 5 | 778655fffd73df101e656154a41b478a1b695116 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-05 | 145 | 121 | 5 | 2beb4ea3838796c580076ab7769de877a3a0552c | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-05 | 148 | 121 | 5 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.36e-05 | 154 | 121 | 5 | 8dc8f02534c3ebda30bf9e702e36d0c53d89e5a5 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.76e-05 | 156 | 121 | 5 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.76e-05 | 156 | 121 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-05 | 161 | 121 | 5 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.08e-05 | 162 | 121 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-Treg|Multiple_Sclerosis / Disease, Lineage and Cell Type | 8.08e-05 | 162 | 121 | 5 | 975d52e3cc101e7592425128e1099d30847a8a42 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.08e-05 | 162 | 121 | 5 | 0acb8f7b51bf422d4f4f8e99bd10360163ae4eb7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-05 | 162 | 121 | 5 | 80619a93c57fe16daf91dc571874ef9ac888953d | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.31e-05 | 163 | 121 | 5 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.56e-05 | 164 | 121 | 5 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 8.81e-05 | 165 | 121 | 5 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 167 | 121 | 5 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 167 | 121 | 5 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 167 | 121 | 5 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 9.59e-05 | 168 | 121 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.86e-05 | 169 | 121 | 5 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 172 | 121 | 5 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 172 | 121 | 5 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.07e-04 | 172 | 121 | 5 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 173 | 121 | 5 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-04 | 174 | 121 | 5 | d67fc8e30cc67fff8f7fdeaccb409d12ca0992c1 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.13e-04 | 174 | 121 | 5 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 175 | 121 | 5 | 22fd7d9b4d403cc8061316855f78bad0eb705ce9 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.19e-04 | 176 | 121 | 5 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 1.19e-04 | 176 | 121 | 5 | 07cde50e1c18fcc2c5028efe1a087db4ef4d4783 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD141+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 1.19e-04 | 176 | 121 | 5 | b9ba7026dee2272c0b483dc0cfa39f74b75f1634 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 177 | 121 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 1.22e-04 | 177 | 121 | 5 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 179 | 121 | 5 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-04 | 180 | 121 | 5 | 2bc3fd2e4c249bf236340c5f0483747faa5c04ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 181 | 121 | 5 | 1b4eb044825ede6361928442524b1988c8ef58b3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-cDC1|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 181 | 121 | 5 | 84ca8c9c036478a6d3a2071919d09065455d417c | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 181 | 121 | 5 | f737f2b1f35747b81fdd8996e289bde5c290af61 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 181 | 121 | 5 | 8d7ebbedc373d55e29da02ac2728b4f4118038f2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.39e-04 | 182 | 121 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-04 | 182 | 121 | 5 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 182 | 121 | 5 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.39e-04 | 182 | 121 | 5 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 182 | 121 | 5 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 182 | 121 | 5 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 183 | 121 | 5 | aed12b743334f3813db0c70d4fe7df90e0673f54 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD141+_DCs|tumor_Lung / Location, Cell class and cell subclass | 1.47e-04 | 184 | 121 | 5 | f5cad8eb358898ae536cd7a7b37d3ce19528b801 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 184 | 121 | 5 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.47e-04 | 184 | 121 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.51e-04 | 185 | 121 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 185 | 121 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.51e-04 | 185 | 121 | 5 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 1.51e-04 | 185 | 121 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.51e-04 | 185 | 121 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.51e-04 | 185 | 121 | 5 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 186 | 121 | 5 | 6575ec6a626cdea169ffd185d47828dfaa29475d | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 1.54e-04 | 186 | 121 | 5 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.58e-04 | 187 | 121 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 187 | 121 | 5 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-04 | 188 | 121 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-04 | 188 | 121 | 5 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 189 | 121 | 5 | 533685a921a65d84107d8d33c43b4fffde019143 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-04 | 189 | 121 | 5 | cfa45fa6b13fcd3f54c29c823885f5b938812474 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 1.66e-04 | 189 | 121 | 5 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 189 | 121 | 5 | dca56ab02bf0505f9a352ff907edaef30906d854 | |
| ToppCell | remission-B_memory|remission / disease stage, cell group and cell class | 1.66e-04 | 189 | 121 | 5 | a7b434a5d2cc7c3952cb8f16d11219b691c6c2b6 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 190 | 121 | 5 | 8e254fc77dd1d2d2a4ce0700af3c37829ca089bf | |
| ToppCell | facs-Marrow-KLS-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 190 | 121 | 5 | a513c1e7df62c28128c932a68b252ee8f0255172 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.75e-04 | 191 | 121 | 5 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| Drug | 2,3-hexanedione | 1.42e-06 | 5 | 120 | 3 | ctd:C043231 | |
| Drug | ibotenic acid | 3.85e-06 | 122 | 120 | 7 | CID000001233 | |
| Drug | aldophosphamide | 7.19e-06 | 24 | 120 | 4 | CID000107744 | |
| Drug | alcophosphamide | 7.84e-06 | 8 | 120 | 3 | CID000098612 | |
| Drug | K-II | 1.19e-05 | 96 | 120 | 6 | CID000129400 | |
| Drug | Glyceraldehyde | 1.67e-05 | 10 | 120 | 3 | ctd:D005985 | |
| Drug | 4-oxoretinaldehyde | 2.75e-05 | 2 | 120 | 2 | ctd:C099660 | |
| Drug | propioin | 2.75e-05 | 2 | 120 | 2 | ctd:C523189 | |
| Drug | dehydroretinal | 2.75e-05 | 2 | 120 | 2 | ctd:C017184 | |
| Drug | Pentanones | 2.75e-05 | 2 | 120 | 2 | ctd:D010422 | |
| Drug | 4-hydroxyretinal | 2.75e-05 | 2 | 120 | 2 | ctd:C057180 | |
| Drug | antiarol | 2.75e-05 | 2 | 120 | 2 | CID000069505 | |
| Disease | Autistic Disorder | 9.39e-06 | 261 | 116 | 8 | C0004352 | |
| Disease | Profound Mental Retardation | 1.90e-05 | 139 | 116 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.90e-05 | 139 | 116 | 6 | C0025363 | |
| Disease | Mental deficiency | 1.90e-05 | 139 | 116 | 6 | C0917816 | |
| Disease | Dent disease (implicated_via_orthology) | 4.58e-05 | 3 | 116 | 2 | DOID:0050699 (implicated_via_orthology) | |
| Disease | Acute Confusional Senile Dementia | 4.59e-05 | 99 | 116 | 5 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 4.59e-05 | 99 | 116 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 4.59e-05 | 99 | 116 | 5 | C0750901 | |
| Disease | Presenile dementia | 4.59e-05 | 99 | 116 | 5 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 4.59e-05 | 99 | 116 | 5 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 4.81e-05 | 100 | 116 | 5 | C0276496 | |
| Disease | Alzheimer's Disease | 5.05e-05 | 101 | 116 | 5 | C0002395 | |
| Disease | Breast Carcinoma | IL24 SYNE1 BCHE EEF1B2 ALKBH8 PIK3CB MTHFR ITSN2 SLC39A6 MED12 | 5.42e-05 | 538 | 116 | 10 | C0678222 |
| Disease | Intellectual Disability | 7.07e-05 | 447 | 116 | 9 | C3714756 | |
| Disease | Alzheimer's disease (is_marker_for) | 7.29e-05 | 257 | 116 | 7 | DOID:10652 (is_marker_for) | |
| Disease | aldose reductase measurement | 9.15e-05 | 4 | 116 | 2 | EFO_0801364 | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 9.15e-05 | 4 | 116 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 9.15e-05 | 4 | 116 | 2 | cv:CN293514 | |
| Disease | triglyceride change measurement, intermediate density lipoprotein measurement | 9.15e-05 | 4 | 116 | 2 | EFO_0007681, EFO_0008595 | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 9.15e-05 | 4 | 116 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.52e-04 | 5 | 116 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.52e-04 | 5 | 116 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 2.27e-04 | 6 | 116 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 2.27e-04 | 6 | 116 | 2 | C0410189 | |
| Disease | butyrylcholinesterase measurement | 2.27e-04 | 6 | 116 | 2 | EFO_0004571 | |
| Disease | Mammary Carcinoma, Human | 2.36e-04 | 525 | 116 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.36e-04 | 525 | 116 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 2.43e-04 | 527 | 116 | 9 | C1458155 | |
| Disease | Malignant neoplasm of breast | IL24 SYNE1 GSDMB BCHE PPA1 EEF1B2 ALKBH8 PIK3CB MTHFR SYNE2 ITSN2 SLC39A6 MED12 | 3.15e-04 | 1074 | 116 | 13 | C0006142 |
| Disease | osteopetrosis (implicated_via_orthology) | 3.18e-04 | 7 | 116 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 3.18e-04 | 7 | 116 | 2 | C0751337 | |
| Disease | Drug toxicity | 3.43e-04 | 84 | 116 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 3.43e-04 | 84 | 116 | 4 | C0041755 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 3.59e-04 | 85 | 116 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | metabolite measurement | 3.78e-04 | 560 | 116 | 9 | EFO_0004725 | |
| Disease | symmetrical dimethylarginine measurement | 5.42e-04 | 9 | 116 | 2 | EFO_0006523 | |
| Disease | white matter growth measurement | 5.42e-04 | 9 | 116 | 2 | EFO_0009335 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 6.51e-04 | 43 | 116 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 8.23e-04 | 11 | 116 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | Parkinson Disease, Secondary Vascular | 9.86e-04 | 12 | 116 | 2 | C0751414 | |
| Disease | Atherosclerotic Parkinsonism | 9.86e-04 | 12 | 116 | 2 | C0751415 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 9.86e-04 | 12 | 116 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Secondary Parkinson Disease | 9.86e-04 | 12 | 116 | 2 | C0030569 | |
| Disease | Gastrointestinal Diseases | 9.86e-04 | 12 | 116 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 9.86e-04 | 12 | 116 | 2 | C0559031 | |
| Disease | Cholera Infantum | 9.86e-04 | 12 | 116 | 2 | C1565321 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.16e-03 | 13 | 116 | 2 | C3501611 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.16e-03 | 13 | 116 | 2 | EFO_0800474 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 1.35e-03 | 14 | 116 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | anemia (is_implicated_in) | 1.35e-03 | 14 | 116 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | Alopecia, Male Pattern | 1.56e-03 | 15 | 116 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 1.56e-03 | 15 | 116 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 1.56e-03 | 15 | 116 | 2 | C0263477 | |
| Disease | Endometrial Neoplasms | 1.56e-03 | 58 | 116 | 3 | C0014170 | |
| Disease | Seizures | 1.74e-03 | 218 | 116 | 5 | C0036572 | |
| Disease | Colorectal Carcinoma | 1.85e-03 | 702 | 116 | 9 | C0009402 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 2.17e-03 | 65 | 116 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | squamous cell carcinoma (is_implicated_in) | 2.25e-03 | 18 | 116 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 2.25e-03 | 18 | 116 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | inflammatory bowel disease (is_implicated_in) | 2.51e-03 | 19 | 116 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | event free survival time, urinary bladder cancer | 2.51e-03 | 19 | 116 | 2 | EFO_0000482, MONDO_0001187 | |
| Disease | Pseudopelade | 2.51e-03 | 19 | 116 | 2 | C0086873 | |
| Disease | Alopecia | 2.51e-03 | 19 | 116 | 2 | C0002170 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.57e-03 | 69 | 116 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | temporal lobe epilepsy (is_marker_for) | 2.78e-03 | 20 | 116 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Manic Disorder | 2.79e-03 | 71 | 116 | 3 | C0024713 | |
| Disease | Bipolar Disorder | 2.84e-03 | 477 | 116 | 7 | C0005586 | |
| Disease | Endometrial Carcinoma | 2.90e-03 | 72 | 116 | 3 | C0476089 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 3.06e-03 | 21 | 116 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.36e-03 | 22 | 116 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | Nasopharyngeal carcinoma | 3.36e-03 | 22 | 116 | 2 | C2931822 | |
| Disease | carnitine measurement | 3.38e-03 | 76 | 116 | 3 | EFO_0010469 | |
| Disease | peak expiratory flow | 3.60e-03 | 498 | 116 | 7 | EFO_0009718 | |
| Disease | Manic | 3.63e-03 | 78 | 116 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 3.77e-03 | 79 | 116 | 3 | C0005587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEQILALEADMTKWE | 556 | Q9Y2J4 | |
| EVLEQLSGLKEFWMD | 201 | Q96RT1 | |
| KVLEMETTVEDLQWD | 271 | O75150 | |
| DVGMVSDILFWILKE | 351 | Q9BRR6 | |
| KVLEMTGNIDEAEWE | 556 | P06276 | |
| LWAAEELDMKAIEAV | 511 | Q9H4A4 | |
| VLESMIDDLQWDIDK | 266 | Q5VTR2 | |
| MEVLTDKEGWILIDR | 61 | Q13829 | |
| LLDMEKEVWEITDAS | 191 | A5X5Y0 | |
| EEAWVLTEELSPKMT | 641 | O94812 | |
| SEEEKMLLESVDWTE | 146 | Q96BT7 | |
| DLKMFEAIGWILEEA | 561 | Q9H7F0 | |
| LTLMDILDTDGDKWL | 56 | Q8TAX9 | |
| LVTDLAGVDWKMTDV | 1771 | Q96L96 | |
| IKQLEDLPMSIEEWA | 1411 | Q8IYW2 | |
| MQEKGVISDILDWKT | 2196 | Q13085 | |
| AWEAMEELVDEGLVK | 141 | O60218 | |
| LLGMDKEVWEITDTS | 191 | Q8WXA8 | |
| LSWIIELLEKDGMAF | 136 | P78545 | |
| LDEAMEWLVETLKSR | 166 | P40616 | |
| SEWDEIEKIMSSIGE | 666 | Q92625 | |
| GVIDLAVDWMTDLKE | 86 | P51793 | |
| IMDVTEEVWDKTLDI | 126 | Q9BTZ2 | |
| GEVKTGELEWLMSLL | 51 | Q8TD86 | |
| PAVLWEESEIMQKEL | 66 | A0A0D9SF12 | |
| VLLEEMDTYEWALKS | 841 | Q8WXS8 | |
| TWAAMEELVDEGLVK | 141 | P15121 | |
| ILSATMEGKLVVWDI | 461 | Q8TBY9 | |
| LDVDGVKVKLQMWDT | 106 | Q9ULW5 | |
| LGSKEESEMIFDWVD | 76 | Q7Z6P3 | |
| TEGEMALIFVNWKEL | 1246 | Q9NZM3 | |
| WFAELSVDMEKILEI | 216 | P24863 | |
| LAMELSAKELEEWEL | 556 | Q8IZ07 | |
| TVSWVKLLEGGEERM | 46 | Q01151 | |
| TSMDLLKKIWEVELI | 911 | Q7Z6G8 | |
| LDKNIPIDDWIMETI | 986 | P43146 | |
| LMDVTEEVWDKTLDI | 126 | Q6PKH6 | |
| ELLKMWGEELTSEES | 416 | P42898 | |
| RAETKEIVSGWLEML | 131 | Q6WCQ1 | |
| KLIDSLEWMDDGLVN | 176 | Q8WVX9 | |
| TLKWEKEEALGEMAT | 1636 | Q8NEZ4 | |
| APEEKIWEELSMLEV | 216 | P43356 | |
| IWEELSMLEVFEGRE | 221 | P43356 | |
| TEWKLEQSMREETLL | 206 | H3BQL2 | |
| EMVQDGIDLKSIKWT | 441 | Q9Y697 | |
| LVEKMDWSIEAAVAT | 141 | O60942 | |
| EISEDTLMFWKGIAD | 251 | Q9Y692 | |
| IADEGTWTLEDRKMV | 71 | Q8WVJ2 | |
| GESEDMSAKERLLLW | 146 | Q03001 | |
| LESLLSWMVDTEELV | 5401 | Q03001 | |
| LLWALTTEGDLKVEM | 16 | Q68D85 | |
| MPSETLWEIAKAEVE | 1 | Q8TCX1 | |
| FEEALGQLVWMDEKT | 516 | P0DPD6 | |
| RDELEWKLSESGAIM | 191 | Q9H2J4 | |
| WKLSESGAIMTDLEE | 196 | Q9H2J4 | |
| LLEDPWKSMESADLV | 186 | O75616 | |
| WKSMESADLVVVLVD | 191 | O75616 | |
| SLDEWLVLIATELMK | 366 | Q8IYU2 | |
| LEETYMLAVTLDEWK | 136 | O94830 | |
| EWAMLLLEIIISGTV | 1556 | Q93074 | |
| VLWLTIELAIVGSDM | 136 | P49279 | |
| LTLEDVWEVDEEMKT | 221 | Q92887 | |
| VWMDDLVKGLLSVED | 86 | Q8WWY8 | |
| DELWEMALSKTIAAL | 371 | Q9Y2D4 | |
| LSLDELWDMLGECLK | 3851 | Q7Z6Z7 | |
| DTMWILGLRKEFEEA | 296 | Q9UKM7 | |
| FDSEEIKPDLWMSLE | 2896 | P78509 | |
| LLEGIVKDMEVWESS | 116 | O15504 | |
| DIVITKLMEDVQIDW | 2161 | Q9UMZ3 | |
| ILLEELDLSSMVIGW | 1641 | Q86UR5 | |
| KMVESTGWVLEEEPA | 576 | Q9NQ11 | |
| PIQTEEMELAIFEKW | 191 | Q9HCM4 | |
| IKSDVWSFGILLMEI | 436 | P08631 | |
| EVEMEEWITILNKIL | 266 | Q9BZ29 | |
| GSLEWELKLMDELAG | 1941 | O43497 | |
| KETLFGELSIENWIM | 71 | Q49AR2 | |
| LTKALGEVDILLTWM | 186 | Q13007 | |
| SEALMLVWDASETEK | 2026 | Q3T8J9 | |
| ALVVEMSWDKGERTE | 616 | P42701 | |
| LGILAMIDEGETDWK | 141 | Q15181 | |
| MIDEGETDWKVIAIN | 146 | Q15181 | |
| LRLLMTEVAWTKDEL | 686 | P14735 | |
| TGEWLDDEVLIKMAS | 121 | O00418 | |
| SILLDVKPWDDETDM | 141 | P24534 | |
| EDEEWPTLEKAATMT | 101 | Q13895 | |
| WIIGSGSKEMLKEIE | 231 | Q8NG08 | |
| VKSDIWSLGITMIEL | 236 | P52564 | |
| MVIGASDVLEETWEK | 151 | Q6ZUA9 | |
| RLDKETTGVMVLAWD | 151 | Q96CM3 | |
| KELLWSTEMADLDEL | 286 | Q5HYW3 | |
| SVIGLMDIKPVDWEE | 451 | Q9BVQ7 | |
| SLGIKELQDWMTDAI | 3286 | Q8NF91 | |
| WLVGQEFELEKMESI | 1916 | Q8WXH0 | |
| EGTRESILVWLTEMD | 6251 | Q8WXH0 | |
| LEDEKATLTLAMADW | 276 | O15061 | |
| DLIVDTMGQEAWVRK | 371 | Q9HB40 | |
| ESLVELLGWTEEMRD | 371 | Q9NTG7 | |
| SEEKILSLVGLSWMD | 156 | P42338 | |
| ELKDAGVATLAWMVI | 586 | Q13433 | |
| LVSELTKGWRVMEQE | 166 | Q8N0Z2 | |
| MLQEIDILEDWTAIK | 216 | Q9HCU9 | |
| EMVEETTWQGLKELG | 126 | P49748 | |
| AWEAMEELVDEGLVK | 141 | C9JRZ8 | |
| TWEAMEDLVITGLVK | 151 | Q96JD6 | |
| MVEAGGLLEKWTLLE | 871 | Q0VD83 | |
| EEEWEAMLPELKSTL | 476 | Q15021 | |
| IDIAADWMTDLKEGI | 146 | P51790 | |
| MESIWETESLDLCLL | 851 | P48736 | |
| KDLEEGIQTLMWRLE | 141 | P01242 | |
| IMEETERAWKAEILS | 341 | Q8ND24 | |
| VARSMGGKEDLIWEL | 271 | P02787 | |
| GSRWLIKEELEEMLV | 196 | P82933 | |
| DMEKVLVVWIEDQTS | 81 | Q96MW7 | |
| IEEVTPLWEETMLKA | 2156 | Q6ZS81 | |
| ILKWLSEMQEEEVEI | 271 | O75830 | |
| WSTLEAETLMKDDEI | 96 | O14795 | |
| KVLSLMDAVDWQEGE | 3181 | Q86WI1 | |
| MGITLDKWVELISED | 26 | Q6GV28 | |
| DLIIFLEEGKESWNM | 51 | O43345 | |
| EIESTQWEIMEKLTR | 96 | Q969W8 | |
| LSDKEMSILLAEEWL | 806 | Q502W6 | |
| MSILLAEEWLDDKSS | 811 | Q502W6 | |
| VLLDGVMVGWVDKDL | 556 | Q9H9Y6 | |
| LTWEKESELPADLEM | 206 | Q8IWV8 | |
| LEFWEGDMVLSVAKL | 576 | Q9NVE5 | |
| EEIAMAVTAWEKGLE | 231 | P56192 | |
| KIEDMAVSLIREEWL | 221 | Q15776 | |
| LWEDVTKMFEGEALL | 31 | Q49AA0 | |
| GWELEEVLLLDMSLD | 196 | Q13224 |